Local Nasal Tolerability and Safety Study of 1146A in Healthy Adult Participants
Status:
Completed
Trial end date:
2016-07-18
Target enrollment:
Participant gender:
Summary
This will be a single-center, randomized, parallel-group, placebo-controlled study to assess
the local nasal tolerability and safety of multiple administrations of topically
(intranasally) administered 1146A delivered by a nasal spray applicator in healthy adult
participants